<DOC>
	<DOCNO>NCT02601066</DOCNO>
	<brief_summary>This research study include patient age 1 25 year old Lamin A/C relate muscular dystrophy ( LMNA-MD ) . The goal study evaluate heart affect child teens LMNA-MD . The evaluation include echocardiogram , electrocardiogram , electrophysiological study implantation subcutaneous ECG holter monitor .</brief_summary>
	<brief_title>Cardiac Arrhythmias Sudden Death Patients Affected With Laminopathies</brief_title>
	<detailed_description>The LMNA relate muscular dystrophy monogenic progressive neuromuscular disorder . Affected pediatric patient present birth childhood classify either congenital muscular dystrophy ( LMNA-CMD ) , congenital onset Limb-girdle muscular dystrophy type 1B ( LGMD1B ) childhood onset Emery Dreifuss muscular dystrophy ( EDMD ) . These distinct clinical presentation involve variant LMNA gene distinguish method inheritance . Those LMNA-CMD new mutation LMNA gene carry either parent , LGMD1B EDMD parent may symptoms variant ( change LMNA gene ) . There current cure treatment LMNA-MD . While heart involvement study adult form LMNA muscular dystrophy . These study identify increase risk arrhythmia ( abnormal heart rhythm ) , conduction defect , cardiomyopathy sudden cardiac death . To date study evaluate age onset heart involvement , type heart involvement , rate heart disease progression risk sudden cardiac death child affect LMNA-MD . The investigator ' research aim evaluate heart involvement child teen affect LMNA-MD . This prospective interventional natural history study . The intervention consist 3 step : 1 ) High complexity echocardiography , 2 ) Electrophysiological Study , 3 ) subcutaneous ECG holter monitor implantation . The duration active protocol last 3 year . Potential subject identify Spanish muscular dystrophy network Congenital Muscle Disease International Registry . The study involve one on-site visit Sant Joan de DÃ©u Hospital Barcelona , Spain ; yearly follow-up arrange individually ( either second visit Barcelona doctor travel see patient ) . At Visit 1 , subject baseline assessment , include echocardiogram , electrocardiogram , electrophysiological study medication review subcutaneous ECG holter monitor implantation . The second study visit occur 12-14 month first study visit . Remote monitoring holter device continue 36 month placement device . For individual travel outside Spain , travel arrangement ease Andres Marcio Foundation</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Death</mesh_term>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<mesh_term>Death , Sudden</mesh_term>
	<criteria>Age onset muscle weakness birth 5 year age Confirmed LMNA relate muscular dystrophy gene mutation AND clinical history ny neuromuscular disorder LMNA relate muscular dystrophy unable comply echocardiogram electrophysiologic study</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>LMNA</keyword>
	<keyword>Sudden Death</keyword>
	<keyword>Neuromuscular</keyword>
</DOC>